𝕏
Latest

Author

Priya Lennox

Regulatory and policy correspondent

Priya Lennox covers FDA and EMA decisions, drug pricing and health policy for PharmaWire, and oversees the FDA decision calendar.

Latest from Priya Lennox

Regulatory

China approves Bayer blood thinner asundexian

China’s drug regulator has approved Bayer’s (BAYN) blood thinner asundexian, a potential boost for the German drugmaker in the world’s second-largest pharmaceutical market as it moves to counter competition from generic medicines.